Adrenocortical Carcinoma with Cushing’s Syndrome and Extensive Tumor Thrombosis of the Inferior Vena Cava in a 30-year-old Filipino Female

Main Article Content

Kristine Abas
https://orcid.org/0000-0001-7641-5833
Maria Honolina Gomez
https://orcid.org/0000-0002-4408-3261
Jennifer Mapanao-Gonong
Rosella Arellano

Abstract

Adrenocortical carcinoma (ACC) is a rare and aggressive neoplasm with poor prognosis.  We report a case of a 30-year-old female who presented with profound classic features of an adrenocorticotrophic hormone (ACTH)-independent Cushing’s syndrome (CS) and a large adrenal mass with massive venous tumor thrombosis of the entire inferior vena cava (IVC), left renal and adrenal veins confirmed by imaging. Adrenal biopsy histopathology and immunohistochemistry confirmed ACC.  Systemic palliative chemotherapy was administered. This rare case presents a unique and atypical presentation of an extensive tumor thrombosis of IVC. With the advanced stage at diagnosis, aggressive nature and poor prognosis of the disease, there is still a need to determine viable therapeutic options for metastatic ACC associated with venous invasion.

Downloads

Download data is not yet available.

Article Details

How to Cite
Abas, K., Gomez, M. H., Mapanao-Gonong, J. ., & Arellano, R. (2022). Adrenocortical Carcinoma with Cushing’s Syndrome and Extensive Tumor Thrombosis of the Inferior Vena Cava in a 30-year-old Filipino Female. Journal of the ASEAN Federation of Endocrine Societies. Retrieved from https://asean-endocrinejournal.org/index.php/JAFES/article/view/1249
Section
Case Reports
Author Biographies

Maria Honolina Gomez, Department of Internal Medicine, Capitol Medical Center, Quezon City, Philippines

Section of Endocrinology, Diabetes & Metabolism, University of Santo Tomas, Faculty of Medicine & Surgery, Manila, Philippines

Jennifer Mapanao-Gonong, Department of Internal Medicine, Capitol Medical Center, Quezon City, Philippines

Section of Oncology, Lung Center of the Philippines, Quezon City, Philippines

References

Else T, Kim AC, Sabolch A, et al. Adrenocortical carcinoma. Endocr Rev. 2014; 35(2):282-326. https://pubmed.ncbi.nlm.nih.gov/24423978. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963263. https://doi.org/10.1210/er.2013-1029.

Libé R. Adrenocortical carcinoma (ACC): Diagnosis, prognosis, and treatment. Front Cell Dev Biol. 2015;3:45. https://pubmed.ncbi.nlm.nih.gov/26191527. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490795. https://doi.org/10.3389/fcell.2015.00045.

Gaujoux S, Mihai R, joint working group of ESES and ENSAT. European Society of En-docrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma. Br J Surg. 2017;104(4):358-76. https://pubmed.ncbi.nlm.nih.gov/28199015. https://doi.org/10.1002/bjs.10414.

Wajchenberg BL, Albergaria Pereira MA, Medonca BB, et al. Adrenocortical carcinoma: clinical and laboratory observations. Cancer. 2000;88(4):711-36. https://pubmed.ncbi.nlm.nih.gov/10679640.

Hedican SP, Marshall FF. Adrenocortical carcinoma with intracaval extension. J Urol. 1997;158(6):2056-61. https://pubmed.ncbi.nlm.nih.gov/24083069. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779390. https://doi.org/10.1016/s0022-5347(01)68152-7.

Kumar S, Choudhary GR, Pushkarna A. Functioning adrenocortical carcinoma with exten-sion up to the right atrium producing Cushing's syndrome. J Clin Imaging Sci. 2013;3:32. https://doi.org/10.4103/2156-7514.116186.

Chiche L, Dousset B, Kieffer E, Chapuis Y. Adrenocortical carcinoma extending into the infe-rior vena cava: Presentation of a 15-patient series and review of the literature. Surgery 2006; 139(1):15–27. https://pubmed.ncbi.nlm.nih.gov/16364713. https://doi.org/10.1016/j.surg.2005.05.014.

Figueroa AJ, Stein JP, Lieskovsky G, Skinner DG. Adrenal cortical carcinoma associated with venous tumour thrombus extension. Br J Urol. 1997;80(3):397-400. https://pubmed.ncbi.nlm.nih.gov/9313656. https://doi.org/10.1046/j.1464-410x.1997.00370.x.

Swan RZ, Hanna EM, Sindram D, Iannitti DA, Martinie JB. Adrenocortical carcinoma with intracaval extension to the right atrium: Resection on cardiopulmonary bypass. Ann Surg Oncol. 2012;19(4):1275. https://pubmed.ncbi.nlm.nih.gov/2227875. https://doi.org/10.1245/s10434-011-2203-4.

Ayati M, Shahbazi J, Tehranchi A, Ayati E, Rezaei Y. Adrenocortical carcinoma with renal vein thrombus extended to inferior vena cava: A case report. Int Surg. 2015;100(7-8):1190-3. https://pubmed.ncbi.nlm.nih.gov/26595492. https://doi.org/10.9738/INTSURG-D-14-00224.1.

Abiven G, Coste J, Groussin L, et al. Clinical and biological features in the prognosis of adrenocortical cancer: Poor outcome of cortisol-secreting tumors in a series of 202 con-secutive patients. J Clin Endocrinol Metab. 2006;91(7):2650-5. https://pubmed.ncbi.nlm.nih.gov/16670169. https://doi.org/10.1210/jc.2005-2730.

Alsabeh R, Mazoujian G, Goates J, Medeiros LJ, Weiss LM. Adrenal cortical tumors clin-ically mimicking pheochromocytoma. Am J Clin Pathol. 1995;104(4):382-90. https://pubmed.ncbi.nlm.nih.gov/7572786. https;//doi.org/10.1093/ajcp/104.4.382

Fassnacht M, Dekkers OM, Else T, et al. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collabo-ration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2018;179(4): G1-G46. https://pubmed.ncbi.nlm.nih.gov/30299884. https://doi.org/10.1530/EJE-18-0608.

Weiss LM, Medeiros LJ, Vickery AL Jr. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol. 1989;13(3):202-6. https://doi.org/10.1097/00000478-198903000-00004.

Kim KH, Park JC, Lim SY, et al. A case of non-functioning huge adrenocortical carcinoma extending into inferior vena cava and right atrium. J Korean Med Sci. 2006;21(3):572-6. https://pubmed.ncbi.nlm.nih.gov/16778409. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729971. https://doi.org/10.3346/jkms.2006.21.3.572.

Berruti A, Terzolo M, Sperone P, et al. Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: A large prospective phase II trial. Endocr Relat Cancer. 2005;12(3):657-66. https://pubmed.ncbi.nlm.nih.gov/16172198. https://doi.org/10.1677/erc.1.01025.